Discontinuation report SANDOZ CIPROFLOXACIN
| Report ID | 280205 |
| Drug Identification Number | 02387131 |
| Brand name | SANDOZ CIPROFLOXACIN |
| Common or Proper name | CIPROFLOXACIN |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | CIPROFLOXACIN |
| Strength(s) | 0.3% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 5ML |
| Anatomical Therapeutical Chemical (ATC) code | S01AE |
| Anatomical Therapeutical Chemical (ATC) description | ANTIINFECTIVES |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2026-03-09 |
| Remaining supply date | |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-03-10 | French | Compare |
| v1 | 2026-03-10 | English | Compare |
Showing 1 to 2 of 2